首页>The Journal of Infectious Diseases>Immunogenicity, safety, and immune persistence of a novel inactivated human enterovirus 71 vaccine: A phase ii, randomized, double-blind, placebo-controlled trial
Immunogenicity, safety, and immune persistence of a novel inactivated human enterovirus 71 vaccine: A phase ii, randomized, double-blind, placebo-controlled trial
作者单位：Center for Disease Control and Prevention, Guangxi Zhuang Autonomous Region, Nanning, China[1]Department of Health Statistics, Fourth Military Medical University, Xi'an, China[2]National Institutes for Food and Drug Control, No. 2, Tiantan Xili, Beijing, 100050, China[3]Sinovac Biotech Co. Ltd., Beijing, China[4]
换一批
换一批
